L-carnitine tartrate allows you to utilize fats as a source of energy during intense exercise
GLP-1s may additionally impact other physiological changes observed in the perimenopausal period, including vasomotor symptoms like hot flashes and night sweats, declines in bone health, and unhealthy changes in body composition (gains in fat mass and declines in muscle mass), but whether these impacts are beneficial or harmful for women's health remains unknown
In the initial stages of treatment, you may still feel hungry or experience cravings, as the medication begins to regulate your appetite
(14) More research needs to be done on the relationship between inflammation and glutathione, but it gives us a clearer starting point in treating these conditions
Temporarily reducing the GLP-1 medication dose or extending the titration schedule may allow better tolerance while maintaining therapeutic benefits
Tucker, M., Liao, G., Park, J., Rosenfeld, M., Wezeman, J., Mangalindan, R., Ratner, D., Darvas, M., & Ladiges, W